AVTX
Avalo Therapeutics Inc.
$18.60
-$0.91(-4.66%)
59
Overall
80
Value
66
Tech
31
Quality
Market Cap
$281.44M
Volume
374.70K
52W Range
$3.39 - $20.72
Target Price
$35.33
EPS Estimates Overview
| Current Quarter | $-1.54 | Next Quarter | $-1.6 |
| Current Year | $-7 | Next Year | $-5.56 |
| QoQ Growth | -3.9% | YoY Growth | +20.6% |
| 3Y EPS CAGR | +91.8% | Target Price | $35.33 |
| Consensus | Buy | Upside | +89.9% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVTX | $18.60 | -4.7% | 374.70K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |